The promise and the problems of epigenetic biomarkers in cancer

Expert Opinion on Medical Diagnostics

Volumn 5, Issue 5, 2011, Pages 375-379

  Lorincz, Attila T ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cancer biomarker; Diagnostics; DNA methylation; Epigenetics; Epigenomics

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; STRUCTURAL PROTEIN; TUMOR MARKER;

ACETYLATION; ASPIRATION BIOPSY; BLOOD ANALYSIS; CANCER DIAGNOSIS; CPG ISLAND; DIAGNOSTIC VALUE; DNA METHYLATION; EDITORIAL; EPIGENETICS; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HISTONE METHYLATION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; URINALYSIS;

EID: 80052058052     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2011.590129     Document Type: Editorial

References (14)

1. Li LC, Carroll PR, Dahiya R. Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst 2005;97:103-15 (Pubitemid 40277090)
2. Baylin SB, Belinsky SA, Herman JG, et al. Aberrant methylation of gene promoters in cancer-concepts, misconcepts, and promise. J Natl Cancer Inst 2000;92:1460-1
3. Cao R, Wang L, Wang H, et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 2002;98:1039-43 (Pubitemid 35247314)
4. Killian JK, Bilke S, Davis S, et al. Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome. Cancer Res 2009;69:758-64
5. Sparano JA. TAILORx: trial assigning individualized options for treatment (Rx). Clin Breast Cancer 2006;7:347-50 (Pubitemid 44717771)
6. Parker JS, Mullins M, Cheang MCU, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009;27:1160-7
7. Cuzick J, Swanson GP, Fisher G, et al. Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Available from: www.thelancet.com/oncology. Published online 9 February 2011
8. Laird PW. Principles and challenges of genome-wide DNA methylation analysis. Nat Rev Genet 2010;11:191-203
9. Yegnasubramanian S, Kowalski J, Gonzalgo ML, et al. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 2004;64:1975-86 (Pubitemid 38339443)
10. Vasiljevic N, Wu K, Brentnall A., et al. Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing. Disease Markers 2011;30:151-61
11. Brandsma JL, Sun Y, Lizardi PM, et al. Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology 2009;389:100-7
12. Li M, Chen WD, Papadopoulos N, et al. Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol 2009;27:858-63
13. Rodriques EF, Santos-Reboucas CB, Goncalves Pimentel MM, et al. Epigenetic alterations of p15 (INK4B) and p16 (INK4A) genes in pediatric primary myelodysplastic syndrome. Leuk Lymphoma 2010;51:1997-4
14. Lefferts JA, Tsongalis GJ. Molecular diagnostics: parallels between infectious disease testing and emerging oncology testing. Expert Opin Med Diagn 2010;4:185-8